()-(1α,2β,5α)-2-(isopropyl)-5-methylcyclohexyl benzoate (38649-18-2)

Identification
Name:	()-(1α,2β,5α)-2-(isopropyl)-5-methylcyclohexyl benzoate
Synonyms:	Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-benzoate, (1R,2S,5R)-rel-;Racemic menthyl benzoate;(1)-(1alpha,2beta,5alpha)-2-(Isopropyl)-5-methylcyclohexyl benzoate;Cyclohexanol, 5-methyl-2-(1-methylethyl)-, benzoate, (1R,2S,5R)-rel-;5-methyl-2-(propan-2-yl)cyclohexyl benzoate
CAS:	38649-18-2
EINECS:	254-061-5
Molecular Formula:	C₁₇H₂₄O₂
Molecular Weight:	260.3713
InChI:	InChI=1/C17H24O2/c1-12(2)15-10-9-13(3)11-16(15)19-17(18)14-7-5-4-6-8-14/h4-8,12-13,15-16H,9-11H2,1-3H3
Molecular Structure:
Properties
Flash Point:	154.9°C
Boiling Point:	341.1°C at 760 mmHg
Density:	1.01g/cm³
Refractive index:	1.513
Flash Point:	154.9°C
Safety Data

Other Product

Cyclohexanol, 5-methyl-2-(1-methylethenyl)-, [1R-(1α,2β,5α)]-, hydroformylation products
(1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
()(1α,2β,5β)-5-methyl-2-(1-methylethyl)cyclohexyl salicylate
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
Silicic acid (H4SiO4), mixed benzyl and (1α,2β,5α)-()-5-methyl-2-(1-methylethyl)cyclohexyl esters
(1α,2β,5α)-4,5-dimethyl-2-(2-methylpropen-2-yl)cyclohex-3-ene-1-carbaldehyde
(1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
[7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
1-Naphthalenepropanol, α-ethenyldecahydro-2-hydroxy-α,2,5,5,8a-pentamethyl-, [1R-[1α(R*),2β,4aβ,8aα]]-, oxidized
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
4α,5-epoxy-5α-androst-2-eno[2,3-d]isoxazol-17β-ol
5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
5-oxo-L-proline, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)
[2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with α-phenylbenzylamine
[7S-(7α,7aα,14α,14aβ)]-dodecahydro-5(or 12)-methyl-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocinium iodide
5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
(1α,2β,4β,6α)-()-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2α,5α,6β)]-, compd. with [R-(R*,S*)]-β-(methylamino)-α-phenylbenzeneethanol (1:1)
(2α,3aβ,5α,6β,6aβ)]-hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol hydrobromide